CFBMC
Transitions in Care: Caring for our Patients Connecting our Partners
Intermittent oxaliplatin administration improves time-to-treatment failure in metastatic colorectal cancer: Final results of the phase III CONcePT trial.
Heartbeats Magazine Winter 2010
2013 KCH Annual Cancer Report | 2012 data
